SpaceX and OpenAI MegaIPOs Raise Concerns Among Analysts Over Potential Market Peak Softcat Raises Profit Guidance Amidst Robust Corporate AI Technology Adoption Intercontinental Exchange to Launch GPU Compute Futures Suite Targeting Transparency in AI Infrastructure Costs Palantirs AI Momentum Faces Market Correction Amid Broader Selloff US Oil Producers Ramp Up Output Amid Price Surge Linked to Iran Conflict Ukraines Drone Advancements Reshape Global Geopolitics and Defense Markets Hudbay Minerals Q1 2026 Earnings EPS Beats Estimates Amid Copper Price Support Stock Slips Viking Holdings VIK Q1 2026 Earnings NarrowerThanExpected Loss Amid Solid Booking Momentum Sable Offshore Corp Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Challenges HSLV Q1 2026 Earnings Silver Explorer Reports Stunning EPS Surprise Despite Absence of Revenue NNOX Q4 2025 Earnings WiderThanExpected Loss as Revenue Details Remain Scarce AGNCN Q1 2026 Earnings Strong EPS Beat Driven by Stable Net Interest Spread CHS Inc CHSCO Holds at 2624 After Slight Pullback as Consolidation Persists EchoStar SATS Holds Steady Near Resistance as Volume Patterns Suggest Consolidation Aurora Mobile JG Slides 895 as Selling Pressure Mounts Near Support Blueport Acquisition Rights BPACR Edges Higher as Speculative Trading Volume Picks Up Foremost Clean Energy Warrants Surge FMSTW Climbs Nearly 10 as Momentum Builds OpenAI Reportedly Nears Confidential IPO Filing Signaling a Landmark Moment for AI Sector UTHR Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results Ingram Micro INGM Surges 338 Key Technical Signals in Play BJRI Q1 2026 Earnings Earnings Miss Estimates Amid Mixed Results Autoliv Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher BATRA Q1 2026 Earnings NarrowerThanExpected Loss as Braves Navigate Seasonality VLTO Q1 2026 Earnings EPS Beats Estimates by 435 as Operational Efficiency Shines VLTO Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment